Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Dermatology
Dermatology
FDA: First Treatment for Hidradenitis Suppurativa Approved, SGLT2 Inhibitor Fracture Warnings Strengthened
09/11/2015
The FDA has approved new options for hidradenitis suppurativa and hereditary orotic acuduria.
09/11/2015
Diabetes Q&A
Diabetes Q&A
FDA: DPP-4 Inhibitors Could Cause Severe Joint Pain
08/31/2015
The FDA has warned of severe, disabling joint pain associated with the use of certain common diabetes drugs.
08/31/2015
Diabetes Q&A
Diabetes Q&A
FDA Roundup: New Options for Diabetes, Hypercholesterolemia
08/28/2015
The FDA has approved new options for the treatment of type 2 diabetes and hypercholesterolemia, as well as a new continuous glucose monitoring system.
08/28/2015
FDA Alerts
FDA Alerts
Potential Therapy for Duchenne MD Gets FDA's Rare Pediatric Disease Designation
08/24/2015
The FDA has granted Rare Pediatric Disease Designation for the medication, a therapy for patients with Duchenne muscular dystrophy who are open to skipping exon 51.
08/24/2015
FDA Alerts
FDA Alerts
U.S. FDA approves 'female Viagra' with strong warning
08/19/2015
...
08/19/2015
Sexual Dysfunction
Sexual Dysfunction
FDA Approves First Drug for Hypoactive Sexual Desire Disorder in Women
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015
Sexual Dysfunction
Sexual Dysfunction
FDA Approves First Drug for Hypoactive Sexual Desire Disorder in Women
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015
Sexual Dysfunction
Sexual Dysfunction
FDA Approves First Drug for Hypoactive Sexual Desire Disorder in Women
08/19/2015
The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.
08/19/2015
FDA Alerts
FDA Alerts
FDA warns makers of superbug-prone scopes over testing violations
08/18/2015
By Reuters Staff ...
08/18/2015
FDA Alerts
FDA Alerts
FDA approves use of opioid painkiller in 11-16 year olds
08/17/2015
<p>The U.S. Food and Drug Administration has approved the use of opioid painkiller OxyContin in patients aged 11 to 16 who have not benefited enough from alternatives.</p>
08/17/2015